Invention Grant
US08703713B2 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent 失效
使用抗原肽和化学治疗剂对胰腺癌的联合治疗

  • Patent Title: Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
  • Patent Title (中): 使用抗原肽和化学治疗剂对胰腺癌的联合治疗
  • Application No.: US12674754
    Application Date: 2008-08-19
  • Publication No.: US08703713B2
    Publication Date: 2014-04-22
  • Inventor: Hiroki Yamaue
  • Applicant: Hiroki Yamaue
  • Applicant Address: JP Kanagawa
  • Assignee: Onco Therapy Science, Inc.
  • Current Assignee: Onco Therapy Science, Inc.
  • Current Assignee Address: JP Kanagawa
  • Agency: Kilpatrick Townsend & Stockton LLP
  • International Application: PCT/JP2008/002232 WO 20080819
  • International Announcement: WO2009/028150 WO 20090305
  • Main IPC: A61K38/00
  • IPC: A61K38/00
Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
Abstract:
Described herein is a combination therapy suited to the treatment of pancreatic cancer and the like. Also described is a method of potentiating the therapeutic effect of chemotherapeutic agents such as gemcitabine.
Information query
Patent Agency Ranking
0/0